Stocks Fall as Treasury Yields Hit Multidecade Highs

Analysts Reportedly Update Ratings on Five Stocks

Analyst views were mixed across the biotech stocks: Wall Street Zen moved ADARx to hold and cut ACADIA Pharmaceuticals to hold, while HC Wainwright reaffirmed buy ratings on Celldex Therapeutics and Connect Biopharma. Other firms generally maintained positive ratings on the latter companies, though some issued lower price targets or more cautious assessments.

US Futures Rise After Softer Economic Data